Analyst Ratings for TransMedics Group (TMDX)
TMDX Rating Summary
TMDX Price Target Summary
- Highest: $175.00 (Oppenheimer)
- Lowest: $115.00 (Stifel)
- Average: $154.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$154.00 (+18.8%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
Avg. $ Target:
$154.00 (+18.8%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/23/2025 | Needham » Updated 2/25/2026 |
Mike Matson | Upgrade | Buy (Hold) |
174.00 (166.00) |
119.54 (129.61) |
8.42% | Details |
| 10/13/2025 | Jefferies | Young Li | New Coverage | Buy (N/A) |
145.00 (N/A) |
112.98 (129.61) |
14.72% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
